Genetic pathways of vascular calcification

Area of Science:

• Cardiovascular Genetics
• Vascular Biology
• Biomineralization

Background:

• Vascular calcification is a significant risk factor for cardiovascular disease, increasing with age.
• Genome-wide association studies link genetic regions, including 9p21, to both vascular calcification and myocardial infarction.
• Both common variants and rare genetic defects contribute to accelerated vascular calcification.

Purpose of the Study:

• To review the genetic causes of medial vascular calcification.
• To highlight recent discoveries in gene mutations affecting extracellular matrix phosphate production.
• To explore the role of S100 proteins in promoting vascular calcification.

Main Methods:

• Review of genetic studies, including genome-wide association studies.
• Analysis of mutations in genes regulating extracellular pyrophosphate and phosphate metabolism (e.g., ENPP1, NTE5).
• Examination of the role of common conditions (atherosclerosis, diabetes) and molecular factors (oxidative stress, inflammation) in secondary calcification.

Main Results:

• Loss-of-function mutations in ENPP1 cause infancy-associated calcification.
• Mutations in NTE5 are linked to adult-onset vascular calcification.
• Vascular calcification involves an osteogenic transformation of vascular smooth muscle and matrix, influenced by genetic predisposition, metabolic factors, and inflammation.

Conclusions:

• Genetic factors, including mutations in ENPP1 and NTE5, are primary drivers of vascular calcification.
• Vascular calcification is a complex process involving genetic predisposition, metabolic dysfunction, inflammation, and osteogenic signaling.
• Further research into genetic regulators and S100 proteins may reveal new therapeutic targets for cardiovascular disease.